Researchers in Russia have introduced a new approach to treating purulent peritonitis, as reported by TASS.
Peritonitis is a severe inflammation of the peritoneum that often accompanies a rapid decline in overall health and can endanger a person’s life. In its most serious form, the condition carries a low chance of survival, and affected patients typically require urgent medical care and nearly always surgical intervention. Over the years, the medical community has pushed for better outcomes, yet some treatment methods have changed slowly, with antibiotics showing improvement mainly in the last three decades.
At Sechenov University, doctors propose a shift in the surgical method to an active laparostomy. This technique involves using temporary barrier membranes during the operation. The goal is to develop a mobile device that can support active drainage and to introduce this technology into clinics across Russia and partner nations. Presently, the surgical management of peritonitis follows a sequence of multiple, lengthy steps.
Officials say that adopting this method could raise survival rates by as much as forty percent. This would be especially important in mass casualty scenarios or when a large number of patients with severe internal injuries arrive for treatment. The move aims to streamline care timelines and improve outcomes in challenging clinical environments.
Separately, scientists have announced that self assembled molecules previously created by chemists hold potential to neutralize cancer cells by disrupting their ability to process oxygen. This line of research adds to the growing spectrum of innovations in biomedicine and offers a glimpse of future therapies that may complement surgical care and infection control in complex cases.